2,382 followers
Jordan Lake and colleagues report a 21% prevalence of hepatic steatosis / NAFLD among PWH with low CV risk who participated in the REPRIEVE study. The participants were ~ 50 yrs, with average BMI 27 kg/m2, CD4 607 / ul, and > 98% with HIV RNA < 400 c